NASDAQ: QNRX
Quoin Pharmaceuticals Ltd Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their QNRX stock forecasts and price targets.

Forecast return on equity

Is QNRX forecast to generate an efficient return?

Company
-3,440.7%
Industry
134.01%
Market
46.57%
QNRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is QNRX forecast to generate an efficient return on assets?

Company
-2,016.03%
Industry
103.31%
QNRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

QNRX earnings per share forecast

What is QNRX's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$15.38

QNRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
QNRX$5.67N/AN/A
LIPO$2.28N/AN/A
LYRA$0.09$2.00+2,198.85%Hold
BCLI$0.86N/AN/A
SLXN$0.72$5.00+592.52%Strong Buy

Quoin Pharmaceuticals Stock Forecast FAQ

What is QNRX's earnings growth forecast for 2025-2025?

(NASDAQ: QNRX) Quoin Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Quoin Pharmaceuticals's earnings in 2025 is -$8,962,472.

In 2025, QNRX is forecast to generate -$316,704,760 in earnings, with the lowest earnings forecast at -$316,704,760 and the highest earnings forecast at -$316,704,760.

If you're new to stock investing, here's how to buy Quoin Pharmaceuticals stock.

What is QNRX's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: QNRX) forecast ROE is -3,440.7%, which is considered weak.

What is QNRX's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: QNRX) Quoin Pharmaceuticals's current Earnings Per Share (EPS) is N/A. In 2025, QNRX's EPS is forecast to hit -$15.38 (min: -$15.38, max: -$15.38).

What is QNRX's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: QNRX) forecast ROA is -2,016.03%, which is lower than the forecast US Biotechnology industry average of 103.31%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.